Metraipolis › archive › dc_f6ecc04ea478
Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation — Europe PMC PMID:41903207
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41903207
- DOI
- 10.1093/stmcls/sxag015
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T22:58:47.894Z
- SHA-256 of the archived text
a62179b7a7ff37966554be44a26d7876be366a0917208c27aabd290a693f8a83- Stable URL of this page
https://metraipolis.com/documento/dc_f6ecc04ea478
How to cite
Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation — Europe PMC PMID:41903207 — Europe PMC (en), https://europepmc.org/article/MED/41903207 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6ecc04ea478 (Metraipolis archive dc_f6ecc04ea478, sha256 a62179b7a7ff37966554be44a26d7876be366a0917208c27aabd290a693f8a83)
BibTeX
@misc{dcf6ecc04ea478,
title = {Stem cell therapies to modulate harmful immune responses in kidney disease: progress toward clinical validation — Europe PMC PMID:41903207},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41903207},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6ecc04ea478; sha256 a62179b7a7ff37966554be44a26d7876be366a0917208c27aabd290a693f8a83},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41903207. Agents can read the archived copy with the MCP tool read_document.